Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00287313 · ClinicalTrials.gov registry record · NA
Daily Vitamin K in Patients on Warfarin With Unstable INRs
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT00287313 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 15 participants.
The verdict
NCT00287313, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if daily Vitamin K supplementation stabilizes INRs in patients taking warfarin with a history of frequent dose changes or variable INRs.
Interventions
- DRUG Vitamin K
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00287313
The ClinicalTrials.gov registry entry for NCT00287313 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin K is the first listed.
NCT00287313 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00287313 about?
NCT00287313 is a clinical study titled "Daily Vitamin K in Patients on Warfarin With Unstable INRs". The purpose of this study is to determine if daily Vitamin K supplementation stabilizes INRs in patients taking warfarin with a history of frequent dose changes or variable INRs.
What is the current status of trial NCT00287313?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2005-10. Estimated completion is 2006-05.
What interventions are being tested in trial NCT00287313?
The interventions under investigation include: Vitamin K (DRUG).
Who is sponsoring clinical trial NCT00287313?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.